Correlation Between Allogene Therapeutics and BioXcel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and BioXcel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and BioXcel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and BioXcel Therapeutics, you can compare the effects of market volatilities on Allogene Therapeutics and BioXcel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of BioXcel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and BioXcel Therapeutics.
Diversification Opportunities for Allogene Therapeutics and BioXcel Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Allogene and BioXcel is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and BioXcel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioXcel Therapeutics and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with BioXcel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioXcel Therapeutics has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and BioXcel Therapeutics go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and BioXcel Therapeutics
Given the investment horizon of 90 days Allogene Therapeutics is expected to generate 0.89 times more return on investment than BioXcel Therapeutics. However, Allogene Therapeutics is 1.13 times less risky than BioXcel Therapeutics. It trades about -0.02 of its potential returns per unit of risk. BioXcel Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 268.00 in Allogene Therapeutics on August 29, 2024 and sell it today you would lose (16.00) from holding Allogene Therapeutics or give up 5.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allogene Therapeutics vs. BioXcel Therapeutics
Performance |
| Timeline |
| Allogene Therapeutics |
| BioXcel Therapeutics |
Allogene Therapeutics and BioXcel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and BioXcel Therapeutics
The main advantage of trading using opposite Allogene Therapeutics and BioXcel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, BioXcel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioXcel Therapeutics will offset losses from the drop in BioXcel Therapeutics' long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| BioXcel Therapeutics vs. Terns Pharmaceuticals | BioXcel Therapeutics vs. Amylyx Pharmaceuticals | BioXcel Therapeutics vs. Acumen Pharmaceuticals | BioXcel Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |